Regulus Therapeutics
RGLS
$2.13
Share price
-4.05%
Change (1 day)
67.72%
Change (1 year)
Categories
Number of shares outstanding for Regulus Therapeutics (RGLS)
Number of shares outstanding as of April 2024 : 19,628,815
According to Regulus Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 19,628,815. At the end of 2023 the company had 19,628,815 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Regulus Therapeutics from 2022 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 19.62 M | 16.56% |
| 2022 | 16.83 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 2,507,200,000 | 12,673.06% | 🇫🇷 France |
 Biogen BIIB | 144,800,000 | 637.69% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,057,000,000 | 10,379.49% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 15,682.92% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,028,000,000 | 10,231.75% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | 177,171,000 | 802.61% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | 73,916,400 | 276.57% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | 125,220,000 | 537.94% | 🇺🇸 USA |